Step by Step

INTRODUCTION

ABIM and DOB Data Collection

9/26/2023 - Medical Grand Rounds: Bench to Bedside: ASCVD: current treatments, emerging therapies, and the potential for engineered vascular systems

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Discover the latest breakthroughs and innovative treatments in the realm of coronary artery disease with Dr. John Pacella and Dr. Dan Shiwarski in this captivating Medicine Grand Rounds lecture. They will be discussing cutting-edge research that bridges the gap between laboratory discoveries and real-world patient care. From the bench to your bedside, witness the evolution of our understanding and approach to tackling this widespread cardiovascular challenge.

Educational Objectives:

Upon completion of this activity, participants should be able to:

    • Evaluate current 3D biofabrication capabilities for translational medicine
    • Describe state-of-the-art 3D bioprinting for cardiovascular tissue engineering
    • Recommend 3D bioprinting as a platform to test clinical therapeutics 

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested additional Reading:

  • Shiwarski DJ, Hudson AR, Tashman JW, Feinberg AW. Emergence of FRESH 3D printing as a platform for advanced tissue biofabrication. APL Bioengineering (2021)
  • Lee A, Hudson AR, Shiwarski DJ, Tashman J, Hinton TJ, Yerneni S, Bliley J, Campbell PG, Feinberg AW. 3D Printing of Collagen to Rebuild Components of the Human Heart. Science (2019). PMID: 31371612
  • Niklason, L. E. & Lawson, J. H. Bioengineered human blood vessels. Science (New York, N.Y.) 370, (2020).
  • Bliley JM, Shiwarski DJ, Feinberg AW. 3D-bioprinted human tissue and the path toward clinical translation. Sci. Transl. Med. (2022) 


Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Dan Shiwarski, PhD — Assistant Professor, Department of Bioengineering, Vascular Medicine Institute, University of Pittsburgh School of Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
John Pacella, MD — Professor of Medicine, Division of Cardiology, University of Pittsburgh School of Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.